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Abstract
Protein ubiquitination is a post-translational protein modification that regulates many biological conditions [1,2,3,4]. Trip12
is a HECT-type E3 ubiquitin ligase that ubiquitinates ARF and APP-BP1 [5,6]. However, the significance of Trip12 in vivo is
largely unknown. Here we show that the ubiquitin ligase activity of Trip12 is indispensable for mouse embryogenesis. A
homozygous mutation in Trip12 (Trip12
mt/mt) that disrupts the ubiquitin ligase activity resulted in embryonic lethality in the
middle stage of development. Trip12
mt/mt embryos exhibited growth arrest and increased expression of the negative cell
cycle regulator p16 [7,8,9,10]. In contrast, Trip12
mt/mt ES cells were viable. They had decreased proliferation, but maintained
both the undifferentiated state and the ability to differentiate. Trip12
mt/mt ES cells had increased levels of the BAF57 protein
(a component of the SWI/SNF chromatin remodeling complex) and altered gene expression patterns. These data suggest
that Trip12 is involved in global gene expression and plays an important role in mouse development.
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Introduction
Protein ubiquitination plays an important role in various
cellular events [1,2,3,4]. Ubiquitination occurs through sequential
steps that are catalyzed by activating (E1), conjugating (E2), and
ligase (E3) enzymes. In this reaction, the specificity for distinct
substrates is determined by the ubiquitin ligase enzymes. From a
mechanistic standpoint, ubiquitin ligases fall into two groups:
HECT domain E3s and RING domain E3s [11,12,13]. The
HECT family contains a diverse N-terminal region and a
conserved C-terminal HECT domain, which has a reactive Cys
residue. HECT-type ubiquitin ligases form a thioester intermedi-
ate with ubiquitin at the conserved Cys residue before transferring
ubiquitin to the target proteins [12,13].
Trip12 encodes a HECT domain containing an E3 ubiquitin
ligase,which wasoriginallyidentified as athyroidhormonereceptor-
interacting protein in a yeast two-hybrid screen [14]. Recent reports
indicate that Trip12 ubiquitinates ARF and APP-BP1 and regulates
BAF57 turnover [5,6,15]. In this study, we showed that the ubiquitin
ligase activity of Trip12 is essential for mouse development. We
generated mice in which the coding region of the HECT domain
within Trip12 was mutated (Trip12
mt/mt mice). Targeted inactivation
of Trip12 resulted in abnormal p16 induction and embryonic
lethality in mice. We also found that Trip12
mt/mt ES cells were viable
but had decreased cell cycle progression. Trip12
mt/mt ES cells had
accumulated levels of the BAF57 protein and different gene
expression patterns. Our data suggest that Trip12 is involved in
global gene expression and is essential for mouse development.
Results
Generation of Trip12 mutant mice
To study the function of Trip12 in vivo, we generated Trip12
mutant mice by replacing exon 33 with FLAG and HA epitope tag
sequences in frame and a neomycin resistant gene. This mutant
Trip12 lacks the catalytic core for the ubiquitin ligase activity and
has FLAG and HA epitope sequences at the C-terminus (Fig. 1A).
The targeting vector was linearized, electroporated into ES cells
and ES cells were grown under G418 selection. Selected ES cell
clones were verified by Southern blot analysis and several clones
were correctly targeted (Fig. 1B). We also detected the mutant
Trip12 proteins in the targeted clones by Western blotting using
an anti-HA antibody (Fig. 1C). Heterozygous Trip12
+/mt mice were
viable and fertile and did not exhibit any overt phenotype. To
elucidate the Trip12 expression pattern in mouse embryos, anti-
HA staining was performed. As shown in Fig. 1D, Trip12 is
ubiquitously expressed in the embryo at E9.5 (Fig. 1D).
TRIP12 ubiquitin ligase activity is essential for mouse
embryogenesis
Trip12
+/mt mice were intercrossed in order to produce Trip12
mt/mt
mice. However, no Trip12
mt/mt mice were generated, suggesting that
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development. To characterizethetimingof this embryonic lethality,
embryos derived from the Trip12
+/mt intercross were genotyped at
different stages of gestation. Trip12
+/+, Trip12
+/mt,a n dTrip12
mt/mt
embryos wereborn at the expected Mendelianratioandwereviable
up to E8.5, while no Trip12
mt/mt embryos were observed between
E11.5 and E13.5 (Table 1). From these results, we concluded that
Trip12 plays an important role in mouse embryogenesis.
Phenotypes of Trip12
mt/mt embryos
To characterize the nature of this embryonic lethality, we
studied the morphology of embryos from timed Trip12
+/mt
intercrosses at different stages of gestation. An examination of
these embryos at various developmental stages revealed that the
development of Trip12
mt/mt embryos appeared to be delayed at
E8.5 (Fig. 2A). Despite this developmental delay, there were no
gross morphological abnormalities in Trip12
mt/mt embryos. We also
confirmed that the number of somites was decreased in Trip12
mt/mt
embryos compared to wild-type embryos at E9.5 (Fig. 2B).
The Trip12
mt/mt embryos were further characterized histologi-
cally at different developmental stages. In addition to a
developmental delay, Trip12
mt/mt embryos had abnormal placenta
formation (Fig. 2C). Normal labyrinth formation was not observed
and a number of erythrocytes accumulated in the placenta of
Figure 1. Generation of Trip12 mutant mice. (A) Schematic representation of the Trip12 gene targeting construct. Exon 33 of Trip12 genomic
DNA containing the Cys residue that is required for ubiquitination was replaced in frame with FLAG and HA epitope tag sequences. Thus, the Trip12
mutant protein has FLAG and HA epitope tags instead of ubiquitination activity. Solid rectangles represent the exons of the Trip12 gene. (B) Southern
blot analysis of the targeted allele in heterozygote Trip12 mutant ES cells. (C) Western blot analysis of Trip12 mutant protein expression in ES cells. (D)
Whole mount immunohistochemistry of wild-type and heterozygous Trip12 embryos using an anti-HA antibody.
doi:10.1371/journal.pone.0025871.g001
Table 1. Genotypes of the offspring from Trip12
+/mt
intercrosses.
No. of mice with the following
genotype:
Age +/+ +/mt mt/mt Absorbed Empty Total
E7.5 7 (23.3%) 17 (56.6%) 6 (20.0%) 0 0 30
E8.5 3 (27.3%) 6 (54.5%) 2 (18.2%) 0 0 11
E9.5 15 (31.3%) 23 (47.9%) 8 (16.7%) 0 2 (4.1%) 48
E10.5 18 (32.7%) 30 (54.5%) 6 (10.9%) 0 1 (1.8%) 55
E11.5 9 (27.3%) 15 (45.5%) 0 9 (27.3%) 0 33
E12.5 2 (28.6%) 2 (28.6%) 0 3 (42.9%) 0 7
E13.5 4 (26.7%) 9 (60.0%) 0 2 (13.3%) 0 15
Newborn 4 (30.8%) 9 (69.2%) 0 - - 13
3 weeks 17 (36.2%) 30 (63.8%) 0 - - 47
Percentage shows the ratio of each genotype in total number of embryos in
each developmental stages.
doi:10.1371/journal.pone.0025871.t001
Trip12 Is Essential for Mouse Embryogenesis
PLoS ONE | www.plosone.org 2 October 2011 | Volume 6 | Issue 10 | e25871Figure 2. Analysis of wild-type (+/+) and Trip12 mutant (mt/mt) embryos. (A) Different developmental stages (E8.5 to E10.5) of wild-type (+/+)
and Trip12 mutant (mt/mt) embryos. (6magnification) (B) The somite number of Trip12
+/+, Trip12
+/mt, and Trip12
mt/mt embryos. The somite number of
each embryo at E9.5 was scored by stereo microscopy. **, p,0.001; N.S., not significant. (C) Hematoxylin and eosin staining of sections of wild-type
(+/+) and Trip12 mutant (mt/mt) embryos at different developmental stages (E7.5 to E9.5). Placental tissues at E9.5 are enlarged in the right panel.
Scale bars represent 1 mm. (D) The expression levels of negative cell cycle regulators in wild-type (+/+) and Trip12 mutant (mt/mt) embryos. Total
RNA was isolated from embryos, and the gene expression profiles were analyzed using real-time RT-PCR. Data are presented as the mean+s.d., n=3.
**, p,0.001; N.S., not significant.
doi:10.1371/journal.pone.0025871.g002
Trip12 Is Essential for Mouse Embryogenesis
PLoS ONE | www.plosone.org 3 October 2011 | Volume 6 | Issue 10 | e25871Trip12
mt/mt embryos (Fig. 2C right panel). This phenotype might
be caused by impaired development of the allantois [16].
Given Trip12 enzymatic activity which is involved in ARF
regulation (4), we examined whether mutant show altered
expression of ARF and related proteins which could explain the
developmental arrest of Trip12
mt/mt embryos. Therefore, we
examined the expression levels of several cell cycle-related genes
and found that p16 and ARF expression levels were increased in
Trip12
mt/mt embryos (Fig. 2D). p16 is a cyclin-dependent kinase
inhibitor and ARF increases p53 protein stability and promotes
p53-dependent cell cycle arrest [7,8,9,10]. However, the expres-
sion level of p21, a p53 target gene, was virtually unchanged. In
addition, mutant embryo didn’t show increased apoptosis
compared to wild type embryo at corresponding developmental
stage (Fig. S1). These data indicate that the embryonic lethality of
Trip12
mt/mt mice may be caused by abnormal p16 induction rather
than p53 activation.
Generation and characterization of Trip12
mt/mt ES cells
To further investigate the function of Trip12, we generated two
Trip12
mt/mt ES cell clones [17 and #2] (Fig. 3A, 3B, and 3C). We
examined the ability of Trip12
mt/mt ES cells to self-renew and
differentiate. The expression levels of Nanog and Oct-4 were
comparable in the two Trip12
mt/mt ES cell clones and wild-type
cell cultures with or without LIF (Fig. 3D). To assess whether ES
cell differentiation was affected, we compared embryoid body (EB)
formation on days 0 and 10. Trip12
mt/mt ES cells displayed the
same EB morphology (data not shown), and the expression
patterns of endodermal (AFP)-, mesodermal (Flk-1)-, and ectoder-
mal (NCAM)-specific genes were also similar between wild-type
and Trip12
mt/mt ES cells (Fig. 3E). These results suggest that Trip12
has a minor role in ES cell differentiation.
Trip12
mt/mt ES cells exhibit cell cycle defects
Next, we tested whether the Trip12 mutation leads to a defect in
cell proliferation. The MTT assay showed that Trip12
mt/mt ES cells
had decreased cell growth (Fig. 4A). Therefore, we analyzed cell
cycle progression by flow cytometry, and found that the G2-M and
SubG1 populations were increased in Trip12
mt/mt ES cells (Fig. 4B).
We further examined the expression levels of p16, ARF, and p21.
Unexpectedly, the expression levels of these genes were virtually
unchanged in the cells (Fig. 4C). It was previously reported that
Trip12 ubiquitinates ARF and inhibits p53-dependent transcrip-
tion [6]. However, there were no detectable alterations in p53-
related protein levels in Trip12
mt/mt ES cells (Fig. 4D).
Trip12 negatively regulates BAF57 protein stability and is
involved in global gene expression in ES cells
Recent reports also suggest that Trip12 regulates BAF57 protein
turnover [15]. Therefore, we examined whether inactivation of the
Trip12 ubiquitin ligase activity affects the stability of BAF57. As
shown in Fig. 5A, the endogenous BAF57 protein levels were
increased in Trip12
mt/mt ES cells (Fig. 5A). We also confirmed that
endogenous BAF57 interacts with Trip12mt from targeted allele in
ES cells (Fig. 5B). In addition, cycloheximide experiments showed
that the turnover rate of endogenous BAF57 was decreased in
Trip12
mt/mt ES cells (t1/2&6 h) compared to that in wild-type cells
(t1/2<4 h) (Fig. 5C). As shown in Fig. 5D, ectopically expressed
wild type and mutant Trip12 were interacting with GST-BAF57
and mutant Trip12 showed stronger interaction than wild type
suggesting that loss of catalytic activity of Trip12 resulted in
decreased dissociation of BAF57 from Trip12. These data
demonstrate that the ubiquitin ligase activity of Trip12 is required
for BAF57 turnover in ES cells. BAF57 is a component of the
SWI/SNF chromatin remodeling complex and involved in a
variety of cellular processes [18,19,20,21,22,23,24,25,26]. There-
fore, a gene expression study using microarray analysis was
performed to elucidate the underlying mechanism that leads to cell
proliferation defects in Trip12
mt/mt ES cells. Microarray analysis of
variance identified a total of 7635 genes that were significantly
expressed in wild-type and Trip12
mt/mt ES cells (p-values,0.05). To
identify statistically significant functional categories by gene
ontology, we selected genes that had greater than 2-fold changes
in expression and placed these genes into DAVID [27]. As shown
in Fig. 5D, both up- and down-regulated genes were enriched in
the developmental process (Fig. 5D). These data suggest that
Trip12 regulates gene expression by destabilizing BAF57 during
mouse development.
Discussion
In this report, we have determined that the E3 ubiquitin ligase
activity of Trip12 is indispensable for mouse development. Previous
reports indicated that Trip12 promotes the ubiquitination and
degradation of ARF [6]. The down-regulation of Trip12 expression
stabilizes ARF and enhances ARF-dependent, p53-mediated cell
cycle arrest in normal human fibroblasts [6]. However, in our
experiments, the p53 pathway was not activated in either Trip12
mt/mt
miceorTrip12
mt/mtEScells.AlthoughTrip12
mt/mtmicehadincreased
ARF expression levels, the p21 (which is a well known p53 target
gene) expressionlevelswereunchanged inthesemice.These findings
suggest that the growth arrest phenotype of Trip12
mt/mt mice was
caused by p16 expression rather than ARF induction. Previous
reports also showed that Trip12-mediated ARF ubiquitination is
inhibited by c-Myc [6]. It is known that c-Myc expression levels are
higher in mouse embryos and ES cells compared to differentiated
cells [17,28,29,30]. Considering these results, we speculate that
Trip12 minimally contributes to ARF ubiquitination during mice
embryogenesis because of elevated c-Myc expression. On one hand,
our experiments showed that BAF57 protein stability was regulated
by Trip12-mediated ubiquitination and that the expression profiles
of several genes were changed between wild-type and Trip12
mt/mt ES
cells. This finding suggests that the ubiquitination activity of Trip12
istightlyregulated byindividual target proteins.Furtherexperiments
using conditional knockout approaches and the Trip12 protein
complex that is purified from different cell types may help elucidate
the exact in vivo functions of the Trip12 protein.
Materials and Methods
Cell culture and embryoid body (EB) formation
E14 ES cells (ATCC) were maintained on mouse embryo
fibroblast (MEF) feeder cell layers in Dulbecco-modified Eagle
medium containing 14% KnockOut Serum Replacement (Invirto-
gen), 1% fetal bovine serum, 100 units/ml LIF, 0.1 mM
nonessential amino acids, 1 mM sodium pyruvate, 2 mM L-
glutamine, and 100 mM 2-mercaptoethanol. For EB formation
assays, 2610
5 cells were seeded into 35 mm low attachment sterile
cell plate in 2 ml ES cell medium without LIF. Fresh medium was
provided every two days.
Targeting vectors and generation of Trip12 mutant mice
The targeting vectors for Trip12 were constructed by inserting
FLAG and HA epitope tag sequences in frame and Neo or IRES-
hyg cassette into the exon 33 of the mouse Trip12 genome.
Trip12 Is Essential for Mouse Embryogenesis
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blastocysts, producing chimeric mice. Highly chimeric males were
mated to females, and then the progeny were intercrossed. All
experiments were performed in accordance with the Declaration
of Helsinki and were approved by University of Tsukuba Ethics
Committee for Animal Experiments (approval ID:040042).
Figure 3. Generation and characterization of Trip12 mutant (mt/mt) ES cells. (A) Schematic representation of the Trip12 gene targeting
construct (Targeted allele II). Solid rectangles represent the exons of the Trip12 gene. (B) Southern blot analysis of the targeted allele in Trip12 mutant
(mt/mt) ES cells. (C) Western blot analysis of Trip12 mutant protein expression in ES cells. (D) Expression levels of Nanog and Oct-4 in Trip12 mutant
(mt/mt) ES cells with or without LIF. The cells were cultured without LIF and harvested at the indicated time points. Total RNA was isolated from ES
cells, and the gene expression profiles were analyzed using real-time RT-PCR. Data are presented as the mean+s.d., n=3. (E) Embryoid body (EB)
formation of wild-type (+/+) or Trip12 mutant (mt/mt) ES cells. The cells were cultured in suspension in ES cell medium without LIF in 10-mm dishes
for 10 days. Scale bars: 100 mm. Total RNA was isolated from the cells, and the gene expression profiles were analyzed using real-time RT-PCR. Data
are presented as the mean+s.d., n=3.
doi:10.1371/journal.pone.0025871.g003
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Cells were lysed in TNE buffer [10 mM Tris-HCl (pH 7.8), 1%
NP-40, 150 mM NaCl, 1 mM EDTA, 1 mM phenylmethylsulfo-
nyl fluoride, and 1 mg/ml aprotinin]. The proteins were separated
by SDS-PAGE, transferred onto PVDF membranes (Millipore),
immunoblotted with indicated antibodies. The antibodies em-
ployed in this study included mouse monoclonal antibodies specific
for b-Actin (Sigma); rat monoclonal antibody for HA (Roche) and
ARF (Calbiochem). Rabbit polyclonal antibody for BAF57
(GeneTex) and Trip12 (Bethyl Laboratories).
Real-time RT-PCR
Embryos and cells were homogenized in 1 ml of sepasol (nacalai
tesque) and total RNA was extracted according to the instruction
manual. cDNA was synthesized from total RNA using RevatraAce
reverse transcriptase (Toyobo) and random primers. Real-time
PCRs were performed to amplify fragments representing for the
indicated mRNA expression. We used primers 59-C A T C T G G A G -
CAGCATGGAGTC-39 and 59-GGGTACGACCGAAAGAGT-
TCG-39 for p16,5 9-GTTCTTGGTCACTGTGAGGATTCAG-39
and 59-CCATCATCATCACCTGGTCCAG-39 for ARF,5 9-
TTGCACTCTGGTGTCTGAGC-39 and 59-TGCGCTTGGA-
GTGATAGAAA-39 for p21,5 9-TTGGGTCTCAGGCAAACT-
CT-39 and 59-CTGTTGGCCCTTTTGTTTTG-39 for p27,5 9-
AGTACCTCAGCCTCCAGCAGAT-39 and 59-GCTTGCACT-
TCATCCTTTGGTT-39 for Nanog,5 9-CACGAGTGGAAAG-
CAACTCA-39 and 59-TTCATGTCCTGGGACTCCTC-39 for
Oct-4,5 9-CATGAACAGGTTCATCTATG-39 and 59-GTTGT-
CAGCTTTGCAGCATG-39 for AFP,5 9-TGTCTATGTTCGA-
GATTACAG-39 and 59-CATTGAGGTTTGAAATCGAC-39 for
Flk-1,5 9-GGTCATTGTGAATGTACCAC-39 and 59-CCTTTG-
TCCAGCTCATGGTG-39 for NCAM,
Cycloheximide treatment
Cells were treated with 100 mg/ml cycloheximide to prevent de
novo protein synthesis, and lysed at various time points following
cycloheximide treatment. The proteins were then separated by
SDS-PAGE and detected by immunoblotting.
Whole mount immunostaining
Whole mount immunostaining of embryos were performed as
described previously [31].
Figure 4. Cell cycle defects in Trip12 mutant (mt/mt) ES cells. (A) Proliferation of Trip12 mutant (mt/mt) ES cells. The growth rate of wild-type or
Trip12 mutant (mt/mt) ES cells was measured by the MTT assay. (B) Cell cycle progression in Trip12 mutant (mt/mt) ES cells was analyzed by flow
cytometry. (C) The expression levels of negative cell cycle regulators in wild-type (+/+)o rTrip12 mutant (mt/mt) ES cells. Total RNA was isolated from
the cells, and the gene expression profiles were analyzed using real-time RT-PCR. Data are presented as the mean+s.d., n=3. (D) Western blot analysis
of proteins in the p53 pathway in wild-type (+/+) or Trip12 mutant (mt/mt) ES cells.
doi:10.1371/journal.pone.0025871.g004
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PLoS ONE | www.plosone.org 6 October 2011 | Volume 6 | Issue 10 | e25871Figure 5. Loss of the ubiquitin ligase activity of Trip12 induces BAF57 protein accumulation in ES cells. (A) The BAF57 expression levels
in wild-type (+/+) or Trip12 mutant (mt/mt) ES cells. The BAF57 protein levels were determined by immunoblotting, and the signal intensity was
quantified. (B) Co-immunoprecipitation of Trip12 with BAF57. Trip12mt was immunoprecipitated from Trip12mt/mt ES cell lysate with an anti-FLAG
antibody, and the immunoprecipitates were immunoblotted with the indicated antibodies. (C) Trip12 regulates the turnover of BAF57. The cells were
treated with 100 mg/ml cycloheximide and lysed at various time points. The protein lysates were separated by SDS-PAGE and detected by
immunoblotting. (D) Wild type or mutant Trip12 was ectopically expressed with or without myc-tagged BAF57. Myc-BAF57 was immunoprecipitated
with anti-myc antibody and immunoblotted with anti-Trip12 or anti-myc antibody. (E) A comparison of the mouse whole-genome RNA expression
profile between wild-type and Trip12 mutant (mt/mt) ES cells. DAVID and the annotation sources GOTERM_BP2 (Biological process) were used to
identify the functional categories.
doi:10.1371/journal.pone.0025871.g005
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The microarray procedure was performed as described in the
Affymetrix GeneChip Expression Analysis manual (Affimetrix).
Each array was analysed using GeneSpring (Agilent) program.
Patterns were analysed to identify functional categories using
Database for Annotation, Visualization and Integrated Discovery
(DAVID) (http:// david.abcc.ncifcrf.gov) [27]. We used the
functional annotation tool program and reported only GO-
TERM_BP (Biological process) that had p-values of ,0.05.
Statistical analysis
All the data are representative of at least three different
experiments. Statistical analysis was performed using t-test.
Supporting Information
Figure S1 TUNEL staining of wild type E8.5 embryo and
Trip12
mt/mt embryo at corresponding developmental stage.
(TIF)
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